Meningoencephalitis tuberculosis as a paradoxical response to anti-tuberculous therapy in a child with pulmonary tuberculosis - a case report

Main Article Content

Heda Melinda Nataprawira

Abstract

This paper reports a case of meningoencephalitis
tuberculosis as a paradoxical response to anti-tubercu-
lous therapy in a child with pulmonary tuberculosis.

Article Details

How to Cite
1.
Nataprawira H. Meningoencephalitis tuberculosis as a paradoxical response to anti-tuberculous therapy in a child with pulmonary tuberculosis - a case report. PI [Internet]. 15Sep.2016 [cited 30Sep.2020];48(5):312-. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/612
Section
Case Report
Author Biography

Heda Melinda Nataprawira

Department of Child Health, Medical School, Padjadjaran
University, Bandung, Indonesia.
Received 2016-09-12
Accepted 2016-09-12
Published 2016-09-15

References

1. Narita M, Ashkin D, Hollender E, Pitchenik A. Para-
doxical worsening of tuberculosis following antiretroviral
therapy in patients with AIDS. Am J Respir Crit Care Med
1998; 158:156-61.
2. Karagoz T, Altinoz H, Senol T. Paradoxical response to an-
tituberculous therapy. Turkish Resp J 2003;4: 17-20.
3. Janmeja AK, Das SK. Cervico-mediastinallymphadenopathy
as a paradoxical response to chemotherapy in pulmonary
tuberculosis. Respiration 2003; 70:219-20.
4. Subhash HS, Supriya S, Prakash B, Thomas K. Acute respiratory
distress syndrome as paradoxical response to anti-tuberculosis
and anti-retroviral therapy. Indian J Tuberc 2006;53: 157-60.
5. Jain SK, Kwon P, Moss WJ. Management and outcomes of
intracranial tuberculomas developing during antituberculous
therapy: case report and review. Clin Pediatr 2005;44:443-50.
6. Navas E, Martin DP, Moreno L, Pintado V, Cassado JL, Fortun
J et al. Paradoxical reactions of tuberculosis in patients with the
acquired immunodeficiency syndrome who are treated with highly
active antiretroviral therapy. Arch Intern Med 2002; 162:97-9.
7. Orlovic D, Smego RA. Paradoxical tuberculous reactions in
HIV-infected patients. lnt J Tuberc Lung Dis 2001;5:370-5.
8. Lazarus A, Sanders J. Management of tuberculosis choosing
an effective regimen and ensuring compliance. Postgrad Med
2000;108:71-84.
9. Takayama K, Armstrong EL, Kunugi KA, KilburnJO. Inhibi-
tion by ethambutol of myolic acid transfer into the cell wall of
mycobacterium smegmatis. Antimicrob Agents Chemother
1979; 16:240-2.
10. YermaJ, SinghAK, Bhatnagar A, SenS, Bose M. Radio-label-
ling of ethambutol with technetium-99m and its evaluation for
detection of tuberculosis. World J Nucl Med 2005;4:35-46.
11. Das SS, Hall A V, Wareham DW, Britton KE. Infection imaging
with radiopharmaceuticals in the 21 ''century. Braz Arch Bioi
Technol v.45 n.spe Curitiba set. 2002.